Top 5 Most Profitable Pharmaceutical Companies In The World

Page 5 of 5

1. BioNTech SE (NASDAQ:BNTX)

2022 Net Income: $9.94 billion  

2022 Revenue: $18.20 billion

In 2022, BioNTech SE (NASDAQ:BNTX), a German mRNA specialist, encountered challenges stemming from fluctuating COVID-19 vaccine demand, mirroring Moderna’s experience. The year 2023 poses additional difficulties as vaccine demand continues to decline and uncertainties persist. Unlike its partner Pfizer, BioNTech relies solely on the Comirnaty vaccine, which is expected to generate 5 billion euros ($5.4 billion) in sales for 2023.

However, BioNTech SE (NASDAQ:BNTX) experienced growth by expanding its Marburg vaccine plant, adding 250 employees, and increasing its workforce by over 1,500 in 2022. The company also introduced modular factories called BioNTainers, targeting production in Africa, and expanded into Australia and Singapore.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also take a peek at the 20 Cities With The Highest Opioid Deaths In The U.S. and the 15 Most Suicidal States In America. 

Page 5 of 5